With its Trophées de l'Avenir, Europe 1 rewards companies, associations and local authorities each year for their daring, innovation and visionary side.

In contention for the Health Trophy, Urgo has embarked on a research project to develop artificial human skin.

Managing to create an artificial skin.

This is the challenge that Urgo has launched with a research project called Genesis.

A real "medical revolution" in the words of Guirec Le Lous, president of Urgo Medical, who is nominated in the health category of the Europe 1 Trophies of the Future.

"Imagine a patient, a severe burn person who arrives at the hospital. Today the only solution is autografting, that is to say, take skin from where it remains and graft it there. where there are no more "he reminds the microphone of Europe 1.

Stop using autograft

But once the project is completed, "the surgeon will be able to directly apply the [artificial] skin to the patient, and thus allow him to heal much more quickly, with much less pain".

This artificial skin will be used to assume the most complex functions of its natural counterpart.

"A huge scientific and technological challenge," admits Guirec Le Lous.

This is why Urgo has set up a "French dream team" to carry out his project.

The group was thus supported by a laboratory from the AFM-Téléthon, the French Blood Donation Establishment, Dassault Systèmes and LBTI, a joint research unit of the CNRS and the Claude Bernard Lyon University. 1. 

>> Education, health, solidarity, mobility, favorites ... find all the articles on the nominees of the Europe 1 Trophies of the Future here

A project worth 100 million euros

"Over the entire consortium and its entire duration", this research, which began in April 2021, will cost around 100 million euros, of which 22.8 million euros come from BpiFrance, further indicates the president of Urgo Medical.

Genesis has also been certified by the Strategic Committee for the Industry and Health Technologies Sector (CSF ITS).

For his part, Guirec Le Lous "imagines that by the 2030s we will be able to treat the first patients" using artificial skin.